Atara Biotherapeutics, Inc

ATRANASDAQUSD
5.23 USD
0.01 (0.21%)🟢LIVE (AS OF 02:16 PM EDT)
🟢Market: OPEN
Open?$5.22
High?$5.38
Low?$5.13
Prev. Close?$5.24
Volume?23.8K
Avg. Volume?346.2K
VWAP?$5.29
Rel. Volume?0.07x
Bid / Ask
Bid?$4.49 × 100
Ask?$5.31 × 100
Spread?$0.82
Midpoint?$4.90
Valuation & Ratios
Market Cap?42.9M
Shares Out?8.2M
Float?2.6M
Float %?36.0%
P/E Ratio?1.31
P/B Ratio?-1.11
EPS?$4.00
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.82Weak
Quick Ratio?0.82Weak
Cash Ratio?0.57Adequate
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
1.3CHEAP
P/B?
-1.11CHEAP
P/S?
0.35CHEAP
P/FCF?
N/A
EV/EBITDA?
0.9CHEAP
EV/Sales?
0.28CHEAP
Returns & Efficiency
ROE?
-84.9%WEAK
ROA?
161.5%STRONG
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$34.4M
Related Companies
Loading...
News
Profile
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Employees
14
Market Cap
42.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2014-10-16
Address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS, CA 91320
Phone: 805-623-4211